Charting the Course for Patients With High-Risk Colon Cancer: 3 Months Versus 6 Months
November 19th 2020In 5 years, it is estimated that approximately 20% of patients with stage II disease and 35% with stage III disease will experience disease recurrence. These estimates highlight the need to pursue progress in adjuvant systemic therapy in order to decrease recurrence rates and improve survival.
Read More